E-ISSN 2347-6923 | ISSN 2277-4092
 

Original Article 


Cytotoxic Potential of Bhallataka Rasayana in MCF-7 & HT-29 Cancer cell lines

Shivani Sharma, Pramod R Yadav, Galib R, Pradeep Kumar Prajapati.


Abstract
Cancer, the second most prevalent non-communicable disease after ischemic heart disease, presents significant challenges to medical science due to its severe impact on health. Ayurveda, an ancient system of medicine, offers a diverse range of potent cancer treatments that can be integrated into conventional oncological therapies. One such Ayurvedic formulation is Bhallataka Rasayana, derived from Semecarpus anacardium Linn. f., which is referenced in traditional Ayurvedic literature for its therapeutic benefits. This study investigates the cytotoxic potential of Bhallataka Rasayana on breast (MCF7) and colon (HT29) cancer cell lines. The in vitro cytotoxic activity of Bhallataka Rasayana was evaluated using the MTT assay across different concentrations to determine the half-maximal inhibitory concentration (IC50). The results demonstrated that the extract of Bhallataka Rasayana exhibited significant cytotoxic effects against MCF7 and HT-29 cell lines, with IC50 values of 1.0 µg/mL and 2.0 µg/mL, respectively. These findings are notable when compared to the IC50 values of Doxorubicin, a standard chemotherapeutic agent, which are 0.5 µg/mL for MCF7 and 0.3 µg/mL for HT-29. The study highlights the potential of Bhallataka Rasayana as a complementary therapeutic agent in cancer treatment.

Key words: [Semecarpus] [Breast cancer] [MCF-7 Cells] [Anti-oxidant] [Doxorubucin]


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Shivani Sharma
Articles by Pramod R Yadav
Articles by Galib R
Articles by Pradeep Kumar Prajapati
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Sharma S, Yadav PR, R G, Prajapati PK. Cytotoxic Potential of Bhallataka Rasayana in MCF-7 & HT-29 Cancer cell lines. AAM. 2026; 15(Supplement 1): 153-161. doi:10.5455/AAM.59654


Web Style

Sharma S, Yadav PR, R G, Prajapati PK. Cytotoxic Potential of Bhallataka Rasayana in MCF-7 & HT-29 Cancer cell lines. https://www.aamjournal.in/?mno=59654 [Access: February 24, 2026]. doi:10.5455/AAM.59654


AMA (American Medical Association) Style

Sharma S, Yadav PR, R G, Prajapati PK. Cytotoxic Potential of Bhallataka Rasayana in MCF-7 & HT-29 Cancer cell lines. AAM. 2026; 15(Supplement 1): 153-161. doi:10.5455/AAM.59654



Vancouver/ICMJE Style

Sharma S, Yadav PR, R G, Prajapati PK. Cytotoxic Potential of Bhallataka Rasayana in MCF-7 & HT-29 Cancer cell lines. AAM. (2026), [cited February 24, 2026]; 15(Supplement 1): 153-161. doi:10.5455/AAM.59654



Harvard Style

Sharma, S., Yadav, . P. R., R, . G. & Prajapati, . P. K. (2026) Cytotoxic Potential of Bhallataka Rasayana in MCF-7 & HT-29 Cancer cell lines. AAM, 15 (Supplement 1), 153-161. doi:10.5455/AAM.59654



Turabian Style

Sharma, Shivani, Pramod R Yadav, Galib R, and Pradeep Kumar Prajapati. 2026. Cytotoxic Potential of Bhallataka Rasayana in MCF-7 & HT-29 Cancer cell lines. Annals of Ayurvedic Medicine, 15 (Supplement 1), 153-161. doi:10.5455/AAM.59654



Chicago Style

Sharma, Shivani, Pramod R Yadav, Galib R, and Pradeep Kumar Prajapati. "Cytotoxic Potential of Bhallataka Rasayana in MCF-7 & HT-29 Cancer cell lines." Annals of Ayurvedic Medicine 15 (2026), 153-161. doi:10.5455/AAM.59654



MLA (The Modern Language Association) Style

Sharma, Shivani, Pramod R Yadav, Galib R, and Pradeep Kumar Prajapati. "Cytotoxic Potential of Bhallataka Rasayana in MCF-7 & HT-29 Cancer cell lines." Annals of Ayurvedic Medicine 15.Supplement 1 (2026), 153-161. Print. doi:10.5455/AAM.59654



APA (American Psychological Association) Style

Sharma, S., Yadav, . P. R., R, . G. & Prajapati, . P. K. (2026) Cytotoxic Potential of Bhallataka Rasayana in MCF-7 & HT-29 Cancer cell lines. Annals of Ayurvedic Medicine, 15 (Supplement 1), 153-161. doi:10.5455/AAM.59654